European Journal of Cancer

16.6k papers and 544.7k indexed citations i.

About

The 16.6k papers published in European Journal of Cancer in the last decades have received a total of 544.7k indexed citations. Papers published in European Journal of Cancer usually cover Oncology (8.2k papers), Pulmonary and Respiratory Medicine (4.1k papers) and Molecular Biology (3.8k papers) specifically the topics of Cancer Treatment and Pharmacology (1.2k papers), Colorectal Cancer Treatments and Studies (1.2k papers) and Lung Cancer Treatments and Mutations (1.2k papers). The most active scholars publishing in European Journal of Cancer are J.W.W. Coebergh, Jaap Verweij, Jean‐Yves Blay, Carlo La Vecchia and Dirk Schadendorf.

In The Last Decade

Fields of papers published in European Journal of Cancer

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in European Journal of Cancer. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in European Journal of Cancer

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in European Journal of Cancer. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in European Journal of Cancer with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025